Yong Li

Prof. Dr. Yong Li

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
HSHe Sun
He Sun
XDXiao Dan dan
Xiao Dan dan
WLWei Liu
Wei Liu
XLXue Li
Xue Li
ZLzhe lin
zhe lin
YDYuling Ding
Yuling Ding

4 April 2022 in Pharmacological Research
Verified
Journal Article
Closed access
XWXueyu Wang
Xueyu Wang
XSXinting Shao
Xinting Shao
WZWenjun Zhang
Wenjun Zhang
TSTong Sun
Tong Sun
YDYuling Ding
Yuling Ding
YLYong Li
Yong Li

8 November 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
BRBoMi Ryu
BoMi Ryu
YJYunfei Jiang
Yunfei Jiang
HKHyun-Soo Kim
Hyun-Soo Kim
JHJee-Min Hyun
Jee-Min Hyun
SLSangbin Lim
Sangbin Lim
You-Jin JeonYou-Jin Jeon
You-Jin Jeon
Nutraceutical use of algae requires understanding of the diversity and significance of their active compositions for intended activities. Ishige okamurae (I. okamurae) extract is well-known to possess α-glucosidase inhibitory activity; however, studies are needed to investigate its active composition in order to standardize its α-glucosidase inhibitory activity. In this study, we observed the intensity of the dominant compounds of each I. okamurae extract harvested between 2016 and 2017, and the different potency of each I. okamurae extract against α-glucosidase. By comparing the anti-α-glucosidase ability of the dominant compounds, a novel Ishophloroglucin A with highest α-glucosidase inhibitory activity was identified and suggested for standardization of anti-α-glucosidase activity in I. okamurae extract. Additionally, a validated analytical method for measurement of Ishophloroglucin A for future standardization of I. okamurae extract was established in this study. We suggest using Ishophloroglucin A to standardize anti-α-glucosidase potency of I. okamurae and propose the significance of standardization based on their composition for effective use of algae as marine-derived nutraceuticals.

1 November 2010 in Canadian Journal of Microbiology
Verified
Journal Article
Closed access
GXGuangxian Xu
Guangxian Xu
HJHao Jia
Hao Jia
YLYong Li
Yong Li
XLXiaoming Liu
Xiaoming Liu
MLMin Li
Min Li
YWYujiong Wang
Yujiong Wang
The metabolic pathway of phospholipids is one of the most important physiologic pathways in Mycobacterium tuberculosis , a typical intracellular bacterium. The hemolytic phospholipase lip gene (Rv0183) is one of 24 phospholipase genes that have been demonstrated to play critical roles in the metabolism of phospholipids in M. tuberculosis. Quantitative RT–PCR and flow cytometry were used to elucidate the immunological and pathogenic implications of the Rv0183 gene on the inflammatory response following persistent expression of Rv0183 in mouse alveolar macrophage RAW264.7 cells. Our results demonstrate that a time-course-dependent ectopic expression of Rv0183 significantly elevated the expression of IL-6, NF-κB, TLR-2, TLR-6, TNFα, and MyD88 in these alveolar macrophage cells. Furthermore, the persistent expression of Rv0183 induced RAW264.7 cell apoptosis in vitro. These findings demonstrate that the expression of Rv0183 induces an inflammatory response and cell apoptosis in the host cells, suggesting that Rv0183 may play an important role in the virulence and pathogenesis of M. tuberculosis infection.

18 October 2023 in Archiv der Pharmazie
Verified
Journal Article
Closed access
CLChang Lu
Chang Lu
XWXueyu Wang
Xueyu Wang
JMJiahui Ma
Jiahui Ma
MWMengtong Wang
Mengtong Wang
WLWei Liu
Wei Liu
YLYong Li
Yong Li

12 September 2023 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
XSXinting Shao
Xinting Shao
DXDandan Xiao
Dandan Xiao
ZYZhaoyi Yang
Zhaoyi Yang
LJLulu Jiang
Lulu Jiang
YLYong Li
Yong Li
YDYuling Ding
Yuling Ding